Personal tools

MCL coexpression mm9:1576: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002107!7.81e-18!22;UBERON:0007499!7.81e-18!22;UBERON:0006925!7.81e-18!22;UBERON:0009497!7.81e-18!22;UBERON:0000015!7.81e-18!22;UBERON:0002423!7.81e-18!22;UBERON:0006235!7.81e-18!22;UBERON:0008835!7.81e-18!22;UBERON:0003894!7.81e-18!22;UBERON:0004161!7.81e-18!22;UBERON:0008836!7.81e-18!22;UBERON:0009854!1.04e-16!23;UBERON:0009856!1.04e-16!23;UBERON:0002365!1.31e-16!25;UBERON:0002330!1.31e-16!25;UBERON:0005172!3.90e-14!49;UBERON:0005173!3.90e-14!49;UBERON:0002417!3.90e-14!49;UBERON:0000916!3.90e-14!49;UBERON:0009569!6.82e-11!66;UBERON:0003914!2.27e-10!47;UBERON:0003104!6.33e-10!61;UBERON:0009142!6.33e-10!61;UBERON:0005256!1.13e-07!45;UBERON:0005177!2.79e-07!79
|ontology_enrichment_uberon=UBERON:0002107!7.81e-18!22;UBERON:0007499!7.81e-18!22;UBERON:0006925!7.81e-18!22;UBERON:0009497!7.81e-18!22;UBERON:0000015!7.81e-18!22;UBERON:0002423!7.81e-18!22;UBERON:0006235!7.81e-18!22;UBERON:0008835!7.81e-18!22;UBERON:0003894!7.81e-18!22;UBERON:0004161!7.81e-18!22;UBERON:0008836!7.81e-18!22;UBERON:0009854!1.04e-16!23;UBERON:0009856!1.04e-16!23;UBERON:0002365!1.31e-16!25;UBERON:0002330!1.31e-16!25;UBERON:0005172!3.90e-14!49;UBERON:0005173!3.90e-14!49;UBERON:0002417!3.90e-14!49;UBERON:0000916!3.90e-14!49;UBERON:0009569!6.82e-11!66;UBERON:0003914!2.27e-10!47;UBERON:0003104!6.33e-10!61;UBERON:0009142!6.33e-10!61;UBERON:0005256!1.13e-07!45;UBERON:0005177!2.79e-07!79
|tfbs_overrepresentation_for_novel_motifs=0.557864,0.293744,0.529553,0.603273,0.406364,0.618805,0.715644,0.300268,0.310789,0.115752,0.668936,0.702872,0.300533,0.728641,0.424775,0,0.930881,0.397593,1.41491,0.185796,1.22707,2.02858,0.727684,0.404661,0.537749,0.757752,0.274609,0.641282,0.456327,0.645258,0.626183,1.03545,0.395107,0.253145,0.425309,0.20704,0.384813,0.699032,3.49595,0.328675,0.401916,1.52768,0.134724,0.426986,0.0637209,0.591277,0.847828,0.658142,0.370501,0.459555,0.912738,0.786094,0.627649,1.18062,1.19842,1.74508,1.18377,4.02168,1.34464,0.734051,1.01481,1.86856,0.865544,0.901018,0.747985,0.943088,1.33705,1.68977,1.00999,1.54147,0.509047,0.827208,0.152094,1.23259,0.257421,0.245132,0.253065,0.835925,0.997094,0.494135,0.830212,0.948899,0.794502,0.293164,1.1148,0.272382,0.618102,0.227755,0.852952,1.85284,1.40768,1.11989,1.04863,0.412897,0.356133,0.89388,0.297538,1.05152,0.848095,0.20438,1.7727,1.03517,1.16282,0.913356,0.91226,0.631253,0.97421,0.653843,0.499439,0.491483,0.550229,1.16464,0.495367,0.674448,1.41481,0.399936,0.673306,2.51141,0.932233,0.380707,1.23809,0.879184,0.759676,0.834976,1.46955,1.00091,0.724289,1.04166,1.33551,0.416189,1.14546,0.595426,1.3055,0.750642,1.43666,0.143464,0.566955,0.633235,1.3869,2.2222,1.82084,1.34183,0.772375,1.04623,0.905521,1.5287,0.851091,2.18247,0.569503,1.05179,0.230371,0.133815,1.18223,0.343194,0.749664,1.26545,1.8503,1.11626,0.555203,0.566652,1.39653,1.11392,1.00137,0.547782,0.90208,0.741834,0.383572,0.701187,0.745913
}}
}}

Revision as of 20:07, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr11:61191591..61191594,-p5@Slc47a1
Mm9::chr17:29411023..29411074,+p4@BC004004
Mm9::chr17:29411084..29411107,+p5@BC004004
Mm9::chr17:29411130..29411148,+p6@BC004004
Mm9::chr17:29411165..29411174,+p8@BC004004


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0006855multidrug transport0.00591651141402709
GO:0015893drug transport0.00920068870542764
GO:0015238drug transporter activity0.00920068870542764
GO:0042493response to drug0.0147803376408579
GO:0015297antiporter activity0.0149741238396844



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>



TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}